Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IRON: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | IRON |
| Related Diseases | CANCER, FERROPTOSIS, ROS |
Knowledge base pages for this entity
graph TD
IRON["IRON"]
IRON -->|"causes"| Ferroptosis["Ferroptosis"]
IRON -->|"causes"| Phospholipid_Peroxidation["Phospholipid Peroxidation"]
IRON -->|"upregulates"| Glycolysis["Glycolysis"]
IRON -->|"mediates"| SNCA["SNCA"]
IRON -->|"expressed in"| Brain["Brain"]
Hemoglobin["Hemoglobin"] -->|"binds"| IRON
Ferroportin["Ferroportin"] -->|"mediates"| IRON
Ferritin["Ferritin"] -->|"binds"| IRON
TFR1["TFR1"] -->|"mediates"| IRON
TF["TF"] -->|"binds"| IRON
Transferrin["Transferrin"] -->|"binds"| IRON
Ferroptosis -->|"involved_in"| IRON
ALOX15["ALOX15"] -->|"binds"| IRON| Target | Relation | Type | Str |
|---|---|---|---|
| Myelination | involved_in | process | 0.95 |
| Oxidative Stress | causes | process | 0.95 |
| Ferroptosis | causes | process | 0.95 |
| Ferroptosis | mediates | process | 0.95 |
| oxidative stress | mediates | process | 0.95 |
| Phospholipid Peroxidation | causes | process | 0.95 |
| ferroptosis | drives | process | 0.95 |
| Neurotransmitter Synthesis | involved_in | process | 0.95 |
| Mitochondrial Metabolism | involved_in | process | 0.95 |
| Ferroptosis | associated_with | process | 0.95 |
| FTH1 | binds | protein | 0.95 |
| FTMT | binds | protein | 0.90 |
| Microglia | associated_with | cell_type | 0.90 |
| hemoglobin | associated_with | protein | 0.90 |
| Brain | expressed_in | cell_type | 0.85 |
| Pro-inflammatory M1 Phenotype | associated_with | phenotype | 0.85 |
| oxidized polyunsaturated fatty acid phospholipids | mediates | compound | 0.85 |
| SNCA | mediates | protein | 0.85 |
| Microglial Transcriptional State | modulates | phenotype | 0.85 |
| Glycolysis | upregulates | pathway | 0.85 |
| Neurodegeneration | causes | process | 0.80 |
| FERROPTOSIS | causes | phenotype | 0.72 |
| FERROPTOSIS | activates | phenotype | 0.72 |
| ROS | activates | phenotype | 0.64 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Ferroptosis | associated_with | process | 0.95 |
| Hemoglobin | binds | protein | 0.95 |
| Ferroportin | mediates | protein | 0.95 |
| Ferritin | binds | protein | 0.95 |
| TF | binds | protein | 0.95 |
| siderophores | binds | compound | 0.95 |
| Lactoferrin | inhibits | protein | 0.93 |
| Transferrin | binds | protein | 0.90 |
| TFRC | mediates | protein | 0.90 |
| TFRC | binds | protein | 0.90 |
| Transferrin | delivers | protein | 0.90 |
| Transferrin Receptor 2 | transports | protein | 0.80 |
| CANCER | associated_with | disease | 0.64 |
| WNT | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio | 0.838 | neurodegeneration | View |
| Iron-driven lipid peroxidation and GPX4 failure create a fer | 0.750 | neurodegeneration | What mechanisms drive the self-amplifyin |
| SCFA-Producing Bacterial Depletion → Loss of Neuroprotective | 0.700 | neurodegeneration | What are the mechanisms by which gut mic |
| Iron Chelation Therapy Targeting the Labile Iron Pool | 0.640 | neurodegeneration | Can ferroptosis inhibitors prevent BBB d |
| Hepcidin-Iron Set Point Hypothesis | 0.577 | endocrinology | Does TRT-induced erythrocytosis actually |
| H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-S | 0.550 | - | Ferroptosis in ALS and motor neuron dise |
| IRP2-Iron Axis Modulation to Reduce Ferroptotic Vulnerabilit | 0.398 | neurodegeneration | Microglial subtypes in neurodegeneration |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning IRON in their description or question text
Score: 0.550 · unknown disease · 2026-04-16
## Mechanistic Overview H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-Selected ALS Patients starts from the
Score: 0.398 · neurodegeneration · 2026-04-25
NOT RECOMMENDED. Contains a biochemical error that undermines the hypothesis. IREB2 binds to IRE sequences in the 5' UTR